四川新药研发及对策研究

发布时间：2018-04-20 00:15

本文选题：四川 + 新药研发　；参考：《成都中医药大学》2014年硕士论文

【摘要】：目的：研究四川省新药研发的现状,分析制约新药研发的主要因素,探讨四川省新药研发的途径与对策。方法：通过文献查阅、调查实践以及借鉴欧美日等国家和地区与我国新药研发的成功经验或差异,运用管理学swot方法分析四川新药研发现状与发展趋势,为制定四川新药研发对策提供科学依据。结果：通过研究,四川新药研发存在机遇和挑战,特别是四川中药资源、专业技术是新药研发的优势。但是研发与市场需求脱节、研究经费严重不足、专利技术多,成果技术转让少、优质资源流失严重等现状是制约四川新药研发的重要因素。结论：四川新药研发事业要有所创新和成就,就必须打破制约新药研发的因素,充分发挥四川药物资源、人才资源优势,紧紧抓住国家“西部大开发战略”的机遇,针对新药研发中的薄弱环节,重点搭建政府机构、医药科研学术界、制药企业等与新药研发领域的互动、合作平台；多形式融资和整合研发资金,解决新药研发的投入问题；四川是医药资源大省,充分利用四川医药资源优势,研发具有优势特色的新药品种。
[Abstract]:Objective: to study the current situation of new drug research and development in Sichuan province, analyze the main factors restricting new drug research and development, and discuss the ways and countermeasures of new drug research and development in Sichuan province. Methods: based on literature review, investigation practice and successful experiences or differences between Europe, America, Japan and other countries and regions and China, the present situation and development trend of new drug research and development in Sichuan were analyzed by swot method of management. To provide scientific basis for the formulation of new drug research and development countermeasures in Sichuan. Results: through the research, there are opportunities and challenges in new drug development in Sichuan, especially the resources of traditional Chinese medicine in Sichuan, and professional technology is the advantage of new drug research and development. However, the current situation such as the disconnection between R & D and market demand, the serious shortage of research funds, the large amount of patent technology, the small transfer of technology and the serious loss of high quality resources are the important factors restricting the research and development of new drugs in Sichuan. Conclusion: in order to make innovations and achievements in Sichuan's new drug research and development, it is necessary to break down the factors restricting the development of new drugs, give full play to the advantages of Sichuan's drug resources and talent resources, and seize the opportunity of the country's "Great Western Development Strategy". In view of the weak links in new drug research and development, we should focus on setting up the interaction and cooperation platform between government agencies, pharmaceutical research academia, pharmaceutical enterprises and the field of new drug research and development, as well as various forms of financing and integration of research and development funds to solve the problem of investment in new drug research and development. Sichuan is a large province of medical resources. It makes full use of the advantages of Sichuan medical resources to develop new drugs with advantages.
【学位授予单位】：成都中医药大学
【学位级别】：硕士
【学位授予年份】：2014
【分类号】：R95

【参考文献】